Cognitive Biolaw and Neuro-Genetic Regulation in Corporate Governance: an Empirical, Comparative, and Bioethical Framework for Workplace Stress Interventions and Data Privacy
Main Article Content
Abstract
Modern enterprise environments subject employees to unprecedented levels of cognitive load, emotional friction, and operational stress. Despite substantial advances in human neurogenetics, functional neuroimaging, and behavioral genomics, legal and corporate administrative frameworks in developing jurisdictions like India remain fundamentally unequipped to regulate neuro-genetic vulnerabilities, cognitive data privacy, and workplace psychological safety. This research paper addresses the profound statutory and regulatory incongruence across the Companies Act (2013), Mental Healthcare Act (2017), Digital Personal Data Protection (DPDP) Act (2023), and Factories Act (1948) regarding neuro-biological employee rights. Integrating quantitative legal-psychology modeling with functional neuroanatomy, this study maps target genomic polymorphisms—including MAOA-L, COMT Val158Met, DRD4/DRD2, NR3C1, FKBP5, and BDNF—to executive stress responses, impulse control, and burnout susceptibility. Using an empirical mixed-methods design (N = 450) across Tamil Nadu enterprise clusters, we evaluate regional workplace stress metrics, suicide acceleration rates, and transcriptomic NR3C1 promoter methylation patterns in high-stress female corporate cohorts. Furthermore, a comparative legal analysis synthesizes United States biotechnology patent jurisprudence (Myriad, Prometheus, Sequenom) and criminal neurolaw precedents (Roper, Graham, Miller, Weinstein, Nelson) against Indian constitutional privacy protections (Puttaswamy, Selvi). To bridge this regulatory gap, we formulate the SEETHEA Framework (Safety, Equity, Ethics, Tranquility, Humanity, Awareness) alongside a five-tiered policy roadmap establishing the institutional role of Chief PsychoNeuro-Genetic Legal Executive Officers (CPNGLEO). A comprehensive bioethical statement detailing IRB approval, cryptographic data hashing, and cognitive privacy protections completes the study.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Berryessa, C. M., & Cho, M. K. (2013). Ethical, legal, and social implications of advances in neurolaw. Stanford Law & Policy Review, 24(1), 125–151.
Farahany, N. A. (2016). Testing his instincts: Behavioral genetics and the criminal law. Journal of Law and the Biosciences, 3(1), 180–189.
Shen, F. X. (2013). Law and neuroscience: What, why, and where to look. Emory Law Journal, 62(4), 1089–
1116.
Jones, O. D., Marois, R., Farah, M. J., & Greely, H. T. (2013). Law and neuroscience. Journal of
Neuroscience, 33(45), 17624–17630.
Goodenough, O. R., & Prehn, K. (2010). A neuroeconomic approach to law and decision making. Philosophical Transactions of the Royal Society B: Biological Sciences, 365(1538), 237–247.
Pernu, T. K., & Elzein, S. (2020). Genomic profiling and employee privacy: Legal and ethical boundaries in corporate wellness. Bioethics, 34(6), 582–591.
Buchman, D. Z., Skinner, W., & Illes, J. (2010). Negotiating the relationship between addiction, neuroscience, and personhood. AJOB Neuroscience, 1(1), 36–45.
Garland, B., & Frankel, M. S. (2006). Considering neuroscience, law, and policy. Brain and Cognition, 50(3), 415–431.
Scurich, N., & Appelbaum, P. S. (2018). The behavioral genetics of violence and criminal responsibility. Journal of the American Academy of Psychiatry and the Law, 46(2), 212– 220.
Farisco, M., & Petrini, C. (2012). The impact of neuroscience on law and neuroethics.
Functional Neurology, 27(1), 7–15.
Guillen, M. A., & Santos, R. (2019). Corporate governance and employee mental health: A statutory comparative analysis. International Journal of Law and Management, 61(3), 341–358.
Tovino, S. A. (2009). The Genetic Information Nondiscrimination Act in employment settings. Florida State University Law Review, 37(2), 287–332.
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013).
Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012).
Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371 (Fed. Cir. 2015).
Roper v. Simmons, 543 U.S. 551 (2005).
Graham v. Florida, 560 U.S. 48 (2010).
Miller v. Alabama, 567 U.S. 460 (2012).
People v. Weinstein, 591 N.Y.S.2d 715 (N.Y. Sup. Ct. 1992).
State v. Nelson, No. F05-8936 (Fla. 11th Cir. Ct. 2011).
Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1.
Selvi v. State of Karnataka, (2010) 7 SCC 1.
E.P. Royappa v. State of Tamil Nadu, (1974) 4 SCC 3.
Maneka Gandhi v. Union of India, (1978) 1 SCC 248.
Indian Council of Medical Research (ICMR). (2017). National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. New Delhi: ICMR.